Brazil's CADE declares Fleury-Hermes Pardini deal 'complex'
MLex Summary: The Brazilian competition authority has declared medical laboratory firm Fleury's acquisition of rival Hermes Pardini to be "complex." The Administrative Council for Economic Defense, or CADE, said it will...To view the full article, register now.
Already a subscriber? Click here to view full article